These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9069565)

  • 1. Renal protein degradation in streptozotocin diabetic mice.
    Liu S; Barac-Nieto M
    Diabetes Res Clin Pract; 1997 Jan; 34(3):143-8. PubMed ID: 9069565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to demonstrate increased protein turnover and intracellular proteinase activity in livers of mice with streptozotocin-induced diabetes.
    Bond JS
    Diabetes; 1980 Aug; 29(8):648-54. PubMed ID: 7002677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubular cell protein degradation in early diabetic renal hypertrophy.
    Shechter P; Boner G; Rabkin R
    J Am Soc Nephrol; 1994 Feb; 4(8):1582-7. PubMed ID: 8025232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal protein synthesis in diabetes mellitus: effects of insulin and insulin-like growth factor I.
    Barac-Nieto M; Liu SM; Spitzer A
    Am J Kidney Dis; 1991 Jun; 17(6):658-60. PubMed ID: 2042644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein turnover in the hypertrophying kidney.
    Rabkin R; Shechter P; Shi JD; Boner G
    Miner Electrolyte Metab; 1996; 22(1-3):153-6. PubMed ID: 8676809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased turnover of soluble liver proteins in mice with alloxan-induced diabetes.
    Duncan WE; Bond JS
    Am J Physiol; 1981 Aug; 241(2):E151-9. PubMed ID: 7023247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular distribution of 3H--hydrocortisone and its metabolites in the liver and kidneys of normal and alloxan diabetic rats.
    Minchenko AG; Tronjko ND
    Endocrinol Exp; 1988 Mar; 22(1):19-28. PubMed ID: 3259502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.
    Zador IZ; Deshmukh GD; Kunkel R; Johnson K; Radin NS; Shayman JA
    J Clin Invest; 1993 Mar; 91(3):797-803. PubMed ID: 8450061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of carbohydrate-responsive element-binding protein improves kidney injury in streptozotocin-induced diabetic mice.
    Zhang W; Li X; Zhou SG
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):42-47. PubMed ID: 28121358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of phosphatidylcholine biosynthesis in diabetic hypertrophic kidneys.
    Suzuki Y; Fausto A; Hruska KA; Avioli LV
    Endocrinology; 1987 Feb; 120(2):595-601. PubMed ID: 3803292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril attenuates oxidative stress in diabetic rats.
    de Cavanagh EM; Inserra F; Toblli J; Stella I; Fraga CG; Ferder L
    Hypertension; 2001 Nov; 38(5):1130-6. PubMed ID: 11711510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes induces an impairment in the proteolytic activity against oxidized proteins and a heterogeneous effect in nonenzymatic protein modifications in the cytosol of rat liver and kidney.
    Portero-Otín M; Pamplona R; Ruiz MC; Cabiscol E; Prat J; Bellmunt MJ
    Diabetes; 1999 Nov; 48(11):2215-20. PubMed ID: 10535457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential expression of insulin-like growth factor binding proteins-1, -3, and -5 during early diabetic renal hypertrophy in rats.
    Park IS; Kiyomoto H; Alvarez F; Xu YC; Abboud HE; Abboud SL
    Am J Kidney Dis; 1998 Dec; 32(6):1000-10. PubMed ID: 9856516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.
    Sakaguchi M; Isono M; Isshiki K; Sugimoto T; Koya D; Kashiwagi A
    Biochem Biophys Res Commun; 2006 Feb; 340(1):296-301. PubMed ID: 16364254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor in renal hypertrophy in streptozotocin-diabetic rats.
    Guh JY; Lai YH; Shin SJ; Chuang LY; Tsai JH
    Nephron; 1991; 59(4):641-7. PubMed ID: 1766505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of alpha-2u globulin in renal mitochondria of STZ-induced diabetic rats observed by a proteomic method.
    Sun SH; Liu SQ; Cai CP; Cai R; Chen L; Zhang QB
    Ann Endocrinol (Paris); 2012 Dec; 73(6):530-41. PubMed ID: 23131471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallothionein metabolism in the liver and kidney of the streptozotocin-diabetic rat.
    Chen ML; Failla ML
    Comp Biochem Physiol B; 1988; 90(2):439-45. PubMed ID: 3409670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
    Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
    Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.